{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Incidence of toxicity related to VAC treatment in patients with GSTA1 and CYP2C9 genotypes.","groups":[{"id":"OG000","title":"Vincristine, Dactinomycin, Cyclophosphamide (VAC)"}],"populationDescription":"The analysis was abandoned due to low incidence of toxicity. Data were not collected.","reportingStatus":"POSTED","timeFrame":"During the study","title":"Toxicity With GSTA1 and CYP2C9 Genotypes","type":"SECONDARY"}